scholarly journals Issues in Pediatric Prescribing of Psychopharmacological Agents: Perspectives of Pediatricians, Caregivers and Case Workers

2004 ◽  
Vol 1 (1) ◽  
Author(s):  
Jennifer Taub ◽  
Matthew Johnsen ◽  
Christina Breault ◽  
Marjory Kravitz
2004 ◽  
Vol 36 (05) ◽  
Author(s):  
M von Kleinsorgen ◽  
M Hamke ◽  
Y Treffurth ◽  
M Berger ◽  
BL Fiebich ◽  
...  

1960 ◽  
Vol 117 (5) ◽  
pp. 449-453 ◽  
Author(s):  
JAMES P. CATTELL ◽  
SIDNEY MALITZ

1974 ◽  
Vol 74 (6) ◽  
pp. 1169
Author(s):  
Josephine K. Craytor ◽  
Ivan K. Goldberg ◽  
Sidney Malitz ◽  
Austin H. Kutscher

2016 ◽  
Vol 72 ◽  
pp. 37-42 ◽  
Author(s):  
Dennis Löffler ◽  
Kathrin Landgraf ◽  
Antje Körner ◽  
Jürgen Kratzsch ◽  
Kenneth Clifford Kirkby ◽  
...  

Author(s):  
Marie-Christine Dubroeucq ◽  
Jean-Marie Stutzmann ◽  
Franco Manfré ◽  
Marc Capet ◽  
Georg Andrees Böhme

PEDIATRICS ◽  
1995 ◽  
Vol 95 (3) ◽  
pp. 455-456
Author(s):  
David Hepburn ◽  
Joseph Morelli ◽  
William L. Weston

Daily use of low-potency topical steroids is a frequently observed pediatric prescribing pattern.1 Many clinicians believe such a strategy is safe because low-potency topical steroids usually do not suppress levels of plasma cortisol or produce systemic side effects. However, daily use of low-potency steroids may result in suppression of plasma cortisol levels.1-4 Suppression of plasma cortisol levels after use of topical steroids has been observed in a biphasic pattern. There is suppression within 2 weeks of starting daily therapy, then recovery to normal despite continued use, then suppression again after 4 to 6 weeks of daily therapy.2,3


1976 ◽  
Vol 7 (17) ◽  
pp. no-no
Author(s):  
K. E. EICHSTADT ◽  
J. C. REEPMEYER ◽  
R. B. COOK ◽  
P. G. RILEY ◽  
D. P. DAVIS ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document